Malin Müller
Senior research engineer (leave of absence) at Institutionen för immunologi, genetik och patologi; Forskningsprogram: Cancerimmunterapi; Forskargrupp Olle Korsgren
- E-mail:
- malin.muller@igp.uu.se
- Visiting address:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postal address:
- Rudbecklaboratoriet
751 85 UPPSALA - Leave of absence:
- 2020-09-01 -
Researcher at Institutionen för medicinska vetenskaper; Experimentell neurologi
- E-mail:
- malin.muller@neuro.uu.se
- Visiting address:
- BMC, Husargatan 3
75123 UPPSALA - Postal address:
- Box 593
75124 UPPSALA
More information is available to staff who log in.
Publications
Selection of publications
- Factors Associated With Serological Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Rituximab (2022)
- Discovery, optimization and biodistribution of an Affibody molecule for imaging of CD69 (2021)
- Transcriptional profiles of human islet and exocrine endothelial cells in subjects with or without impaired glucose metabolism (2020)
- Comparing the Effects of the mTOR Inhibitors Azithromycin and Rapamycin on In Vitro Expanded Regulatory T Cells (2019)
Recent publications
- Cerebrospinal fluid mtDNA concentrations are increased in multiple sclerosis and were normalized after intervention with autologous hematopoietic stem cell transplantation (2024)
- Antibodies from serum and CSF of multiple sclerosis patients bind to oligodendroglial and neuronal cell-lines (2023)
- Factors Associated With Serological Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Rituximab (2022)
- Discovery, optimization and biodistribution of an Affibody molecule for imaging of CD69 (2021)
- Transcriptional profiles of human islet and exocrine endothelial cells in subjects with or without impaired glucose metabolism (2020)
All publications
Articles
- Cerebrospinal fluid mtDNA concentrations are increased in multiple sclerosis and were normalized after intervention with autologous hematopoietic stem cell transplantation (2024)
- Antibodies from serum and CSF of multiple sclerosis patients bind to oligodendroglial and neuronal cell-lines (2023)
- Factors Associated With Serological Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Rituximab (2022)
- Discovery, optimization and biodistribution of an Affibody molecule for imaging of CD69 (2021)
- Transcriptional profiles of human islet and exocrine endothelial cells in subjects with or without impaired glucose metabolism (2020)
- Comparing the Effects of the mTOR Inhibitors Azithromycin and Rapamycin on In Vitro Expanded Regulatory T Cells (2019)